The Ogun State facility is wholly Nigerian-owned and produces dual active ingredient long-lasting insecticidal nets combining a pyrethroid with chlorfenapyr.
ALMA and Malaria No More UK estimate that a 30% reduction in malaria financing could result in 146 million additional cases, almost 400,000 additional deaths and US$37 billion in lost economic output by 2030.
The plan targets a reduction of at least 50 percent in malaria related deaths and a 40 percent reduction in malaria case incidence by 2030, compared with 2022 levels.
The facility is expected to produce 10 million nets annually at full capacity and create more than 600 jobs.
During the first phase of the study, conducted in Osun State from 2023 to 2025, children who received PMC experienced a 22% reduction in confirmed malaria cases. Overall health facility visits for illness also fell by 19%.
Since South Sudan introduced SMC in 2022, the programme has helped protect children aged three to 59 months from malaria during peak transmission periods.
The partnership traces its roots to 2009, when Vestergaard rehabilitated Emusanda Health Centre in Lurambi and transformed it into a community facility providing primary healthcare, maternal services, paediatric care, and HIV treatment.
NAFDAC released the public alert following a Notice of Concern from the WHO Prequalification service.
The newly formed partnership, operating as SNG Health, represents the first direct investment of its kind in mosquito net production within the country.
The WHO’s African Regional Verification Commission for Measles and Rubella Elimination verified this achievement following its October 2025 meeting in Johannesburg, South Africa.